The long-awaited IPO pickup lost some of its steam in October, as the US government shutdown disrupted timelines and delayed deal activity. Twenty-two IPOs raised a combined $3.2 billion, in line with the 10-year historical average by deal count (21) but well...read more
Three sizable IPOs and four SPACs debuted this week to wrap up October. Three IPOs submitted initial filings. Corporate travel software provider Navan (NAVN) priced its IPO at the midpoint to raise $923 million at a $6.9 billion market cap. The company...read more
MapLight Therapeutics, a Phase 2 biotech developing therapies for neuropsychiatric and CNS disorders, raised $251 million by offering 14.8 million shares at $17. Cornerstone investor T. Rowe Price had indicated on $40 million worth of shares in the offering (16%...read more
Two sizable IPOs are scheduled for the week ahead, both of which launched after the government shutdown began. The first notable name to set terms under the updated SEC guidance, Navan (NAVN) plans to raise $923 million at a $6.9 billion market cap. The...read more
Renaissance Capital's October IPO Market Update
The long-awaited IPO pickup lost some of its steam in October, as the US government shutdown disrupted timelines and delayed deal activity. Twenty-two IPOs raised a combined $3.2 billion, in line with the 10-year historical average by deal count (21) but well...read more
US IPO Weekly Recap: Navan slips, and Medline joins the pipeline to close out October
Three sizable IPOs and four SPACs debuted this week to wrap up October. Three IPOs submitted initial filings. Corporate travel software provider Navan (NAVN) priced its IPO at the midpoint to raise $923 million at a $6.9 billion market cap. The company...read more
CNS disorder biotech MapLight Therapeutics prices IPO at $17, as expected
MapLight Therapeutics, a Phase 2 biotech developing therapies for neuropsychiatric and CNS disorders, raised $251 million by offering 14.8 million shares at $17. Cornerstone investor T. Rowe Price had indicated on $40 million worth of shares in the offering (16%...read more
US IPO Week Ahead: First major post-shutdown launches set to IPO
Two sizable IPOs are scheduled for the week ahead, both of which launched after the government shutdown began. The first notable name to set terms under the updated SEC guidance, Navan (NAVN) plans to raise $923 million at a $6.9 billion market cap. The...read more